/
MMSI
$69.34-$0.75 (-1.07%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$4.3B
60M shares
52-week range
$59.74 – $96.74
26% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$4.79
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $882.8M | $994.9M | $963.9M | $1.07B | $1.15B | $1.26B | $1.36B | $1.51B |
| Cost of revenue | $488.0M | $562.5M | $562.7M | $589.4M | $631.9M | $673.5M | $713.2M | $777.8M |
| Gross profit | $394.8M | $432.4M | $401.2M | $485.3M | $519.1M | $583.9M | $643.3M | $736.9M |
| Gross margin | 44.7% | 43.5% | 41.6% | 45.2% | 45.1% | 46.4% | 47.4% | 48.7% |
| R&D | $59.5M | $65.6M | $57.5M | $71.2M | $75.5M | $82.7M | $83.8M | $97.4M |
| Operating income | $58.6M | $15.4M | −$1.6M | $60.9M | $87.6M | $123.9M | $155.7M | $184.4M |
| EBITDA | $129.4M | $119.3M | $103.6M | $155.0M | $181.2M | $228.9M | $274.0M | $332.0M |
| Net income | $42.0M | $5.5M | −$9.8M | $48.5M | $74.5M | $94.4M | $120.4M | $128.5M |
| Net margin | 4.8% | 0.5% | -1.0% | 4.5% | 6.5% | 7.5% | 8.9% | 8.5% |
| EPS (diluted) | 0.78 | 0.10 | -0.18 | 0.84 | 1.29 | 1.62 | 2.03 | 2.13 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.6B | $4.07 | $4.05–$4.08 | 7 |
| 2027 | $1.7B | $4.40 | $4.28–$4.53 | 7 |
| 2028 | $1.8B | $4.74 | $4.23–$5.41 | 3 |
| 2029 | $1.9B | $5.03 | $4.98–$5.07 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$152.91
Price
$69.34
Implied upside
+121%
Peer comparison
Merit Medical Systems Inc
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
www.merit.com- Employees
- 7,500
- IPO / List date
- May 10, 1990
- HQ
- SOUTH JORDAN, UT
Held by traders on TradeandTell
No one on the platform currently holds MMSI.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 314,212 | $21.7M |
| Bridgewater Associatesas of 2026-03-31 | 5,507 | $379.6K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2011-05-06 | 5-for-4 |
| 2003-12-03 | 4-for-3 |
| 2003-08-15 | 4-for-3 |
Recent trades on TradeandTell
No one on the platform has traded MMSI yet.
